LPL Financial’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
Other funds holding CHRS
TGY2IT
CM
LPL Financial's CHRS Position: Q3 2026 in Review
LPL Financial reduced its Coherus Oncology (CHRS) stake by 4.6% in Q3 2026, selling an estimated $3.01K and leaving 45,967 shares worth $55.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6109.
LPL Financial first reported a position in CHRS in Q4 2023 and has held it in 12 quarters since. The position peaked at $359K in Q3 2025. 135 funds tracked by Wall St. Rank hold CHRS as of Q3 2026.
- LPL Financial held 45,967 shares of Coherus Oncology worth $55.6K as of Q3 2026.
- LPL Financial sold 2,200 Coherus Oncology shares in Q3 2026, an estimated $3.01K.
- Coherus Oncology made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #6109 holding.
- LPL Financial first reported a position in Coherus Oncology in Q4 2023 and has held it in 12 quarters since.
- LPL Financial's Coherus Oncology position peaked at $359K in Q3 2025.
- 135 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2026.
Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.